Julie Williams

Respondent Med-X, Inc., concedes that it failed to file a required report on time and that,as a result, it unknowingly sold shares of its exempt offering while not in compliance with Regulation A’s rules. However, it argues that these errors were committed inadvertently due toits counsel’s misinterpretation of those rules, and that the balance of equities favors vacating theSecurities and Exchange Commission’s temporary suspension of Med-X’s Regulation Aexemption. This initial decision does just that. Inc.